Skip to main content
Top
Published in: Infection 6/2011

01-12-2011 | Clinical and Epidemiological Study

Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003–2009

Authors: A.-M. Giner, S. P. Kuster, R. Zbinden, C. Ruef, B. Ledergerber, R. Weber

Published in: Infection | Issue 6/2011

Login to get access

Abstract

Purpose

The aim of this quality control study was to assess the time to initial diagnostic procedures and the time to the first dose of antibiotics in patients with pneumococcal bacteremia, and to investigate whether the timeliness of these interventions influenced outcome.

Methods

We retrospectively studied patient characteristics, chronological sequence of diagnostic and therapeutic steps, and the course of disease of all patients with pneumococcal bacteremia at a Swiss university hospital between 2003 and 2009, and we analyzed associations between these factors and the length of hospital stay (LOS) and mortality.

Results

A total of 102 episodes of pneumococcal bacteremia in 98 patients were analyzed, of whom 15.7% died during hospitalization. The median time (interquartile range [IQR]) to the first antibiotic dose was 4.0 (2.0–5.9) h, and the median times (IQR]) to blood cultures, chest radiograph, lumbar puncture, and brain computed tomography (CT) scan or magnetic resonance imaging (MRI) were 1.4 (0.5–3.3), 2.5 (1.2–4.2), 4.2 (2.7–7.2), and 2.3 (0.6–6.2) h, respectively. The time to diagnostic procedures and therapy were not associated with LOS or death. Risk factors for death in the univariable analysis were: Charlson comorbidity index [odds ratio [OR] (95% confidence interval) per unit increase, 1.3 (1.1–1.6)], neutropenia [OR 10.1 (2.0–51.0)], human immunodeficiency virus (HIV) infection [OR 3.9 (1.1–13.8)], chronic respiratory disease [OR 4.4 (1.2–16.0)], chronic liver disease [OR 3.2 (1.0–9.7)], smoking [OR 3.8 (1.1–13.5)], injection drug use [OR 9.7 (1.5–63.7)], and antibiotic therapy within 6 months before admission [OR 4.0 (1.3–12.5)]. The multivariable analysis revealed age >60 years (P = 0.048) and alcoholism (P = 0.009) as risks for prolonged LOS.

Conclusions

The outcome of pneumococcal bacteremia may be more influenced by patient characteristics than by minor differences in the timeliness of initial diagnostic and therapeutic measures within the first several hours after hospital admission.
Literature
1.
go back to reference Altclas J, Salgueira C, Di Martino A. Pneumococcal bacteremia in a single center in Argentina. Int J Infect Dis. 2004;8:53–8.PubMedCrossRef Altclas J, Salgueira C, Di Martino A. Pneumococcal bacteremia in a single center in Argentina. Int J Infect Dis. 2004;8:53–8.PubMedCrossRef
2.
go back to reference Fariñas-Alvarez C, Fariñas MC, García-Palomo JD, González-Ruiz M, Fernández-Mazarrasa C, Parra JA, et al. Prognostic factors for pneumococcal bacteremia in a university hospital. Eur J Clin Microbiol Infect Dis. 2000;19:733–41.PubMedCrossRef Fariñas-Alvarez C, Fariñas MC, García-Palomo JD, González-Ruiz M, Fernández-Mazarrasa C, Parra JA, et al. Prognostic factors for pneumococcal bacteremia in a university hospital. Eur J Clin Microbiol Infect Dis. 2000;19:733–41.PubMedCrossRef
4.
go back to reference Laurichesse H, Romaszko JP, Nguyen LT, Souweine B, Poirier V, Guólon D, et al. Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dôme, France, 1994–1998. Eur J Clin Microbiol Infect Dis. 2001;20:299–308.PubMedCrossRef Laurichesse H, Romaszko JP, Nguyen LT, Souweine B, Poirier V, Guólon D, et al. Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dôme, France, 1994–1998. Eur J Clin Microbiol Infect Dis. 2001;20:299–308.PubMedCrossRef
5.
go back to reference Trampuz A, Widmer AF, Fluckiger U, Haenggi M, Frei R, Zimmerli W. Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986–2000. Mayo Clin Proc. 2004;79:604–12.PubMedCrossRef Trampuz A, Widmer AF, Fluckiger U, Haenggi M, Frei R, Zimmerli W. Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986–2000. Mayo Clin Proc. 2004;79:604–12.PubMedCrossRef
6.
go back to reference Berjohn CM, Fishman NO, Joffe MM, Edelstein PH, Metlay JP. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia. Medicine (Baltimore). 2008;87:160–6.CrossRef Berjohn CM, Fishman NO, Joffe MM, Edelstein PH, Metlay JP. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia. Medicine (Baltimore). 2008;87:160–6.CrossRef
7.
go back to reference Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080–4.PubMedCrossRef Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080–4.PubMedCrossRef
8.
go back to reference Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest. 2006;130:11–5.PubMedCrossRef Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest. 2006;130:11–5.PubMedCrossRef
9.
go back to reference Winstein CJ. Neurogenic dysphagia. Frequency, progression, and outcome in adults following head injury. Phys Ther. 1983;63:1992–7.PubMed Winstein CJ. Neurogenic dysphagia. Frequency, progression, and outcome in adults following head injury. Phys Ther. 1983;63:1992–7.PubMed
10.
go back to reference Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med. 2006;119:865–71.PubMedCrossRef Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med. 2006;119:865–71.PubMedCrossRef
11.
go back to reference Chaudhuri A, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15:649–59.PubMedCrossRef Chaudhuri A, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008;15:649–59.PubMedCrossRef
12.
go back to reference Houck PM, Bratzler DW. Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes? Curr Opin Infect Dis. 2005;18:151–6.PubMedCrossRef Houck PM, Bratzler DW. Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes? Curr Opin Infect Dis. 2005;18:151–6.PubMedCrossRef
13.
go back to reference Garnacho-Montero J, García-Cabrera E, Diaz-Martín A, Lepe-Jiménez JA, Iraurgi-Arcarazo P, Jiménez-Alvarez R, et al. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment. Scand J Infect Dis. 2010;42:185–92.PubMedCrossRef Garnacho-Montero J, García-Cabrera E, Diaz-Martín A, Lepe-Jiménez JA, Iraurgi-Arcarazo P, Jiménez-Alvarez R, et al. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment. Scand J Infect Dis. 2010;42:185–92.PubMedCrossRef
14.
go back to reference Cusini A, Rampini SK, Bansal V, Ledergerber B, Kuster SP, Ruef C, et al. Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. PLoS One. 2010;5:e14011.PubMedCrossRef Cusini A, Rampini SK, Bansal V, Ledergerber B, Kuster SP, Ruef C, et al. Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. PLoS One. 2010;5:e14011.PubMedCrossRef
15.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRef
16.
go back to reference Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203.CrossRef Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203.CrossRef
17.
go back to reference Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing, seventeenth informational supplement. M100-S17. CLSI, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing, seventeenth informational supplement. M100-S17. CLSI, Wayne, PA
18.
go back to reference Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9.PubMedCrossRef Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9.PubMedCrossRef
19.
go back to reference Cheng AC, Buising KL. Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia. Ann Emerg Med. 2009;53:618–24.PubMedCrossRef Cheng AC, Buising KL. Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia. Ann Emerg Med. 2009;53:618–24.PubMedCrossRef
20.
go back to reference Yu KT, Wyer PC. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. Ann Emerg Med. 2008;51:651–62, 662.e1–2.PubMedCrossRef Yu KT, Wyer PC. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. Ann Emerg Med. 2008;51:651–62, 662.e1–2.PubMedCrossRef
21.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.PubMedCrossRef Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.PubMedCrossRef
22.
go back to reference Neuman MI, Kelley M, Harper MB, File TM Jr, Camargo CA Jr. Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia. J Emerg Med. 2007;32:349–57.PubMedCrossRef Neuman MI, Kelley M, Harper MB, File TM Jr, Camargo CA Jr. Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia. J Emerg Med. 2007;32:349–57.PubMedCrossRef
23.
go back to reference Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.PubMedCrossRef Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.PubMedCrossRef
24.
go back to reference Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007;131:1865–9.PubMedCrossRef Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007;131:1865–9.PubMedCrossRef
25.
go back to reference Powers JH. Practice guidelines: belief, criticism, and probability. Arch Intern Med. 2011;171:15–7.PubMedCrossRef Powers JH. Practice guidelines: belief, criticism, and probability. Arch Intern Med. 2011;171:15–7.PubMedCrossRef
Metadata
Title
Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003–2009
Authors
A.-M. Giner
S. P. Kuster
R. Zbinden
C. Ruef
B. Ledergerber
R. Weber
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 6/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0218-1

Other articles of this Issue 6/2011

Infection 6/2011 Go to the issue